Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating benign prostate hyperplasia and its preparation process

A technology for benign prostatic hyperplasia and drugs, which is applied in the direction of drug combinations, medical formulas, and medical preparations containing active ingredients, etc., can solve the problems of complex composition of prescriptions, many medicinal flavors, and high prices, and achieve the effect of reducing residual urine volume and stabilizing the curative effect

Inactive Publication Date: 2007-07-04
郭凯
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1. Surgical treatment is traumatic to a certain extent, and there are many intraoperative and postoperative complications, and the elderly have poor tolerance to surgery and anesthesia
[0005] 2. Physiotherapy such as microwave, radio frequency, high-energy focus, etc. can only relieve symptoms in the short term, and there are complications such as urethral stricture
[0006] 3. Drugs that reduce the volume of the prostate, such as finasteride (Proscar), can reduce the volume of the prostate, but the price is more expensive (8 yuan / day), and the onset of effect is slow (onset in March); and can cause Low libido, impotence and other side effects
[0007] 4. Drugs that relieve the symptoms of BPH patients, such as tamsulosin hydrochloride (Hale), the price is 8 yuan / day, which can quickly relieve the clinical symptoms of BPH patients with dysuria, but cannot reduce the size of the prostate and delay the condition of BPH patients Progression; can cause eg headache, orthostatic hypotension, even unacceptable side effects
[0008] Although there are some Chinese patent medicines for the treatment of benign prostatic hyperplasia, they still cannot meet the needs of patients, and their prescriptions are complex, with more medicinal flavors, higher prices, and poor curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0056] The present invention will be further described below in conjunction with embodiment.

[0057] Medicine of the present invention can have multiple different compositions and different proportioning relations, as (consumption is weight percentage):

[0058] (1) Corydalis 50 Dung beetle 50

[0059] (2) Corydalis 40 Dung beetle 60

[0060] (3) Corydalis 30 Dung beetle 70

[0061] (4) Corydalis 20 Dung beetle 80

[0062] (5) Corydalis 10 Dung beetle 90

[0063] (6) Corydalis 57 Dung beetle 43

[0064] (7) Corydalis 60 Dung beetle 40

[0065] (8) Corydalis 70 Dung beetle 30

[0066] (9) Corydalis 80 Dung beetle 20

[0067] (10) Corydalis 90 Dung beetle 10

[0068] For the preparation method of the medicine of the present invention, taking Corydalis Corydalis and Dung Beetle (50:50 by weight percentage) as an example, the following methods can be referred to:

[0069] (1) Directly crush the dung beetle into fine powder; Corydalis is extracted with ethanol backflow, sol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating benign prostate hyperplasia which is prepared from corydalis ambigua and dung beetle. The invention also discloses the process for preparing the medicament comprising steps of disintegrating, solvent extracting and formulating proportionally.

Description

technical field [0001] The invention relates to a medicine for treating benign prostatic hyperplasia. Specifically, it is a Chinese patent medicine prepared from Corydalis Corydalis and Dung Beetle as main raw materials. The present invention also relates to the preparation method of the above-mentioned medicine. Background technique [0002] Benign prostatic hyperplasia (BPH) is a common disease among elderly men, most of whom are after the age of 50, and the incidence rate increases with age. The incidence: 13.2% for 41-50 years old; 51-60 years old 20%; 61-70 years old accounted for 50%; 71-80 years old accounted for 57.1%; 81-90 years old accounted for 83.3%. BPH seriously threatens the health of the elderly. BPH can cause dysuria, dripping, frequent urination, nocturia, etc. Further development can lead to urinary retention, renal insufficiency, bladder stones, severe urinary tract infection and other complications, seriously affecti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/50A61K9/16A61K9/20A61K9/48A61P13/08A61K35/64
Inventor 郭凯
Owner 郭凯
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products